A detailed history of Federated Hermes, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,610,340 shares of BSX stock, worth $140 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,610,340
Previous 1,081,229 48.94%
Holding current value
$140 Million
Previous $83.3 Million 62.07%
% of portfolio
0.31%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $38.6 Million - $44.4 Million
529,111 Added 48.94%
1,610,340 $135 Million
Q2 2024

Aug 08, 2024

BUY
$67.33 - $77.71 $47.4 Million - $54.7 Million
704,464 Added 186.98%
1,081,229 $83.3 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $11.2 Million - $13.4 Million
194,895 Added 107.16%
376,765 $25.8 Million
Q4 2023

Jan 31, 2024

SELL
$48.64 - $57.81 $20,380 - $24,222
-419 Reduced 0.23%
181,870 $10.5 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $71,018 - $77,372
-1,415 Reduced 0.77%
182,289 $9.62 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $1.01 Million - $1.11 Million
20,310 Added 12.43%
183,704 $9.94 Million
Q1 2023

May 08, 2023

BUY
$45.09 - $50.03 $2.13 Million - $2.37 Million
47,341 Added 40.79%
163,394 $8.17 Million
Q4 2022

Feb 13, 2023

SELL
$39.56 - $47.22 $239,733 - $286,153
-6,060 Reduced 4.96%
116,053 $5.37 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $8,443 - $25,221
230 Added 0.19%
122,113 $4.73 Million
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $1.62 Million - $2.17 Million
-46,061 Reduced 27.43%
121,883 $4.54 Million
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $1.09 Million - $1.21 Million
-26,755 Reduced 13.74%
167,944 $7.44 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $6.93 Million - $8.16 Million
181,962 Added 1428.61%
194,699 $8.27 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $29,190 - $32,483
-708 Reduced 5.27%
12,737 $553,000
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $196,796 - $225,668
5,101 Added 61.13%
13,445 $575,000
Q1 2021

May 13, 2021

SELL
$35.27 - $39.67 $32.3 Million - $36.4 Million
-917,208 Reduced 99.1%
8,344 $322,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $32.4 Million - $41.1 Million
-978,258 Reduced 51.38%
925,552 $33.3 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $42.23 $6.85 Million - $8.4 Million
-198,944 Reduced 9.46%
1,903,810 $72.7 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $1.14 Million - $1.47 Million
-37,624 Reduced 1.76%
2,102,754 $73.8 Million
Q1 2020

May 13, 2020

SELL
$25.83 - $45.71 $2.56 Million - $4.53 Million
-99,042 Reduced 4.42%
2,140,378 $69.8 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $12,345 - $14,790
-326 Reduced 0.01%
2,239,420 $101 Million
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $26,927 - $29,024
668 Added 0.03%
2,239,746 $91.1 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $16.4 Million - $20.2 Million
-470,122 Reduced 17.35%
2,239,078 $96.2 Million
Q1 2019

May 10, 2019

SELL
$32.91 - $40.75 $2.65 Million - $3.29 Million
-80,669 Reduced 2.89%
2,709,200 $104 Million
Q4 2018

Feb 13, 2019

SELL
$31.73 - $39.04 $5.62 Million - $6.92 Million
-177,265 Reduced 5.97%
2,789,869 $98.6 Million
Q3 2018

Nov 13, 2018

SELL
$32.83 - $38.63 $7.77 Million - $9.15 Million
-236,804 Reduced 7.39%
2,967,134 $114 Million
Q2 2018

Aug 10, 2018

SELL
$26.84 - $34.32 $1.96 Million - $2.51 Million
-73,181 Reduced 2.23%
3,203,938 $105 Million
Q1 2018

May 09, 2018

BUY
$25.2 - $28.54 $9.39 Million - $10.6 Million
372,435 Added 12.82%
3,277,119 $89.5 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $170,902 - $205,441
6,894 Added 0.24%
2,904,684 $0
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $76.1 Million - $84.5 Million
2,897,790
2,897,790 $84.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.